Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry AMD”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Not applicableLooking for participantsNCT03921931
What this trial is testing

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Who this might be right for
Macular Degeneration, DryPrimary Open-angle Glaucoma
Medical University of Vienna 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06229665
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 75
Not applicableLooking for participantsNCT04129021
What this trial is testing

High Resolution, High-speed Multimodal Ophthalmic Imaging

Who this might be right for
Retinitis PigmentosaMaculopathy, Age RelatedMacular Dystrophy+12 more
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 1,200
Early research (Phase 1)Study completedNCT01922128
What this trial is testing

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
MacuCLEAR, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00346060
What this trial is testing

Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.

Who this might be right for
Dry Age Related Macular Degeneration.
Radtke, Norman D., M.D. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05170048
What this trial is testing

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Who this might be right for
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
Evergreen Therapeutics, Inc. 90
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Not applicableLooking for participantsNCT05706896
What this trial is testing

Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Not applicableLooking for participantsNCT06046118
What this trial is testing

Photobiomodulation in Dry Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 180
Early research (Phase 1)Study completedNCT00950638
What this trial is testing

ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Who this might be right for
Dry Age-Related Macular Degeneration
Ophthotech Corporation 47
Testing effectiveness (Phase 2)Study completedNCT05536752
What this trial is testing

QA102 Phase II Study in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 150
Not applicableUnknownNCT04268836
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Optimal Acuity Corporation 200
Not applicableLooking for participantsNCT06351605
What this trial is testing

A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 500
Not applicableLooking for participantsNCT06662162
What this trial is testing

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationAge-related Macular Degeneration (ARMD)Intermediate AMD+1 more
i-Lumen Scientific AUS PTY LTD 100
Not applicableStudy completedNCT01822873
What this trial is testing

Study on Visual Function Impairments in Dry Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Duke University 128
Not applicableStudy completedNCT03333954
What this trial is testing

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Science Corporation 5
Not applicableUnknownNCT00926861
What this trial is testing

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Who this might be right for
Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 320
Testing effectiveness (Phase 2)Study completedNCT01632527
What this trial is testing

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
StemCells, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT01601483
What this trial is testing

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

Who this might be right for
Nonexudative Age Related Macular Degeneration
MacuCLEAR, Inc. 22
Load More Results